北京商报讯(记者王寅浩)3月25日,药明生物发布2024年度报告显示,2024年药明生物实现营收186.75亿元,同比增长9.6%;毛利为76.51亿元,同比增长12.1%;归母净利润33.56亿元,同比下降1.3%;经调整归母净利润为47.84亿元,同比增长1.8%。(文章来源:北京商报)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.